Debt Syndication & Equity Fund Raising Advisory

Debt syndication is the process of structuring and arranging borrowing from banks or NBFCs — a term loan, working capital facility, or external commercial borrowing — where the company repays principal and interest on a fixed schedule and does not give up any ownership. Equity fund raising advisory is the process of raising capital in exchange for ownership — from angels, family offices, venture capital, or private equity — where there is no repayment obligation but the founders dilute their shareholding and typically grant the investor governance rights. PNPC advises on both, and on blended structures that combine the two.

The starting question is whether the capital need is asset-backed and cash-flow-visible (favouring debt) or growth-stage and risk-bearing with an uncertain near-term repayment capacity (favouring equity). A working capital gap tied to receivables or inventory cycles is typically debt-appropriate. A negative-margin growth phase — customer acquisition, product development, market entry — is typically equity-appropriate because there is no near-term cash flow to service debt. Many growing businesses use both: equity to fund the risk-bearing growth plan and debt, layered in afterward, to fund the asset-backed portion at a lower cost of capital.

CMA (Credit Monitoring Arrangement) data is a standardised financial presentation format — covering operating statement, balance sheet, fund flow statement, and key ratios for past, current, and projected years — that banks and NBFCs use to appraise a credit proposal under RBI-linked lending norms. Nearly every bank's credit department requires CMA data in this format before a term loan or working capital proposal is processed, regardless of the lender. It is not optional paperwork — it is the primary document the credit committee actually analyses.

A straightforward facility from an existing banking relationship — where the bank already has your financials and history — can close in as little as 4–6 weeks from application to disbursement. A new-lender term loan or working capital facility, particularly one requiring fresh collateral valuation and full credit appraisal, typically takes 8–14 weeks. Consortium or multiple-banking arrangements involving more than one lender generally take longer due to inter-lender coordination. These are directional timelines — actual duration depends on documentation completeness, the lender's internal processing capacity, and the complexity of security being offered.

From the first serious investor conversation to funds actually landing in the company's bank account, a typical priced equity round takes roughly 3–6 months. Seed and angel rounds with fewer investors and simpler diligence can close faster — sometimes 6–10 weeks. Larger institutional rounds involving formal due diligence, legal documentation negotiation, and multiple investor committees routinely take 4–6 months or longer. Founders who plan a raise assuming a 6–8 week close are almost always disappointed and put unnecessary pressure on negotiating leverage by running low on runway mid-process.

A term sheet is a document summarising the key commercial terms of a proposed debt facility or equity investment — amount, pricing, tenor or valuation, security or governance rights, and key conditions — agreed in principle before definitive legal documentation is drafted. For equity rounds, most commercial terms in a term sheet are non-binding (an expression of intent), while specific clauses — confidentiality, exclusivity/no-shop, and governing law — are typically binding even at term sheet stage. For debt, a sanction letter functions similarly and is generally treated as binding once accepted, subject to conditions precedent being met.

For equity: liquidation preference (determines who gets paid first and how much on an exit or liquidation event), anti-dilution protection (protects the investor if a future round is priced lower — full ratchet versus weighted average matters significantly), board composition and reserved matters (what decisions require investor consent), and information rights. For debt: covenant package (financial ratios you must maintain), prepayment penalty, cross-default clauses, and personal guarantee scope. Founders frequently focus entirely on the headline number and under-negotiate these structural terms, which have a larger long-term impact than the valuation or rate itself.

FC-GPR (Foreign Currency — Gross Provisional Return) is the RBI reporting form required whenever an Indian company allots equity shares, CCPS, or other FDI-eligible instruments to a person resident outside India. It must be filed on the RBI's FIRMS portal within 30 days of the date of share allotment. This applies whenever any part of your equity round comes from a non-resident investor — whether an NRI, a foreign national, or a foreign fund investing directly or through a permitted FDI structure. Failure to file within 30 days requires a compounding application under FEMA involving penalties and legal cost.

ECB refers to commercial loans raised by eligible Indian entities from recognised non-resident lenders, governed by the RBI's ECB Master Directions. It is typically used for capital expenditure, refinancing of existing debt, or specific permitted end-uses, and can offer a lower effective cost of foreign-currency debt compared to onshore borrowing in some rate environments. It comes with regulatory conditions: minimum average maturity requirements, an all-in-cost ceiling linked to a benchmark rate, restrictions on end-use (working capital funding via ECB is restricted except in specific permitted categories), and mandatory monthly reporting (Form ECB-2) once drawn.

CCPS (Compulsorily Convertible Preference Shares) are a hybrid instrument that carries preference rights (typically a fixed dividend and priority on liquidation) until conversion, and compulsorily converts into equity shares — usually at a pre-agreed ratio — after a specified period or event. CCPS is the standard instrument for VC and PE investment in India, partly because FEMA pricing guidelines and Companies Act provisions are well-established for this instrument, and partly because it allows investors preferential rights during the pre-conversion window while still being treated as equity (not debt) for regulatory and capital structure purposes.

For any equity allotment to a resident or non-resident investor, a defensible valuation basis is required — for FEMA pricing guideline compliance if any investor is a non-resident (shares cannot be issued below the fair value determined under an internationally accepted pricing methodology), and as general governance and negotiation discipline even for all-resident rounds. A valuation report from a SEBI-registered Merchant Banker or a practising Chartered Accountant, prepared under Rule 11UA of the Income-tax Rules or a DCF/comparable methodology as appropriate, is standard practice for priced rounds.

Section 56(2)(viib) of the Income-tax Act — which treated share premium in excess of fair market value from resident investors as taxable income in the company's hands — was abolished by the Finance (No. 2) Act, 2024, with effect from 1 April 2025 (Assessment Year 2025-26 onwards). It no longer applies to shares issued on or after that date. A defensible fair value remains important for FEMA pricing-guideline compliance where any investor is non-resident, and for general governance and negotiation discipline, but the specific angel-tax exposure that historically drove conservative valuations for resident-only rounds is no longer a live concern for current raises.

CMA data (operating statement, balance sheet, fund flow statement, and ratio analysis for past and projected years), the loan application and project report where the facility is tied to capex, and coordination of supporting documents — financial statements, GST/income tax returns, banking statements, and security/collateral documentation. We also prepare the lender comparison and negotiation brief once multiple sanction offers are on the table, so the promoter can compare pricing, tenor, and covenant terms on a like-for-like basis rather than in isolation.

The financial model and projections, the Information Memorandum or investor pitch deck, the cap table and use-of-funds presentation, and valuation basis documentation. During negotiation, we prepare a term sheet comparison and red-flag summary for any non-standard clauses. Post-term-sheet, we review the Share Subscription Agreement and Shareholders' Agreement against the agreed terms before execution, and handle the regulatory filings (PAS-3, FC-GPR) after closing.

Both. We prepare the financial case and materials, and we also identify and approach a shortlist of lenders or investors whose appetite, sector focus, and typical ticket size genuinely match your requirement, based on our practice relationships built since 1986. We accompany founders to credit discussions and investor pitch meetings — in person where practical, or on video calls for our India and UAE clients working across geographies.

PNPC charges a professional advisory fee agreed in writing before engagement begins, structured around the scope of work — financial model preparation, CMA data / IM drafting, lender/investor identification, negotiation support, and closing documentation review. Fee structures vary by mandate — a fixed professional fee, a success-linked component, or a combination, depending on the size and complexity of the raise. We confirm the exact structure in a written scope and fee letter before any work begins; there is no standard percentage quoted without understanding the specific mandate.

A rejection is rarely final and unexplained — credit committees generally decline for identifiable reasons: insufficient debt service coverage ratio, inadequate collateral, adverse CIBIL/credit bureau history, weak financial ratios, or a project report that does not withstand appraisal scrutiny. We review the specific reason with the lender where possible, address the underlying issue — restructure the ask, strengthen the security offered, or correct financial reporting gaps — and, where appropriate, approach a different lender whose risk appetite or sector focus is a better fit.

Most diligence findings are resolvable — a compliance filing that needs to be regularised, a related-party transaction that needs formal documentation, or an IP asset that needs to be formally assigned to the company. The more damaging pattern is when the founder or the company was unaware of the issue before diligence surfaced it, which raises questions about internal financial discipline beyond the specific finding. We run a pre-diligence readiness review before approaching investors specifically to surface and resolve these issues in advance, on our terms and timeline rather than the investor's.

A convertible note (or CCPS with deferred conversion terms) is often more appropriate for early rounds where the business does not yet have enough traction to support a defensible priced valuation, or where speed matters more than precision. It defers the valuation conversation to a future priced round (typically the next round, with a valuation cap and/or discount) and closes faster with simpler documentation. A full priced round makes more sense once there is enough traction — revenue, users, or a clear market signal — to support a valuation that both sides can defend with reasonable confidence.

PNPC operates from Chennai, Bangalore, Hyderabad, and Dubai. For a client with operations or fund-raising needs spanning both jurisdictions — an Indian entity raising from a UAE-based family office, a UAE entity seeking bank financing from a UAE bank, or a group structure with both an Indian and a UAE company — we coordinate the engagement across both offices under a single mandate. This includes India-side FEMA/RBI compliance for any cross-border capital flow, and UAE-side banking relationships and corporate structuring on the other side.

DSCR measures a company's ability to service its debt obligations — broadly, cash flow available for debt servicing divided by total debt obligations (principal plus interest) due in a period. Lenders use DSCR as one of the primary metrics to assess repayment capacity; most banks and NBFCs apply a minimum DSCR threshold (commonly around 1.2–1.5x depending on the lender, sector, and facility type) as an internal credit policy benchmark before sanctioning a term loan. A projected DSCR below the lender's threshold is one of the most common reasons for either rejection or a reduced sanction amount.

A personal guarantee makes the guarantor (typically a promoter or director) personally liable for the outstanding loan amount if the company defaults and lender recovery from company assets is insufficient. Banks routinely require personal guarantees for term loans and working capital facilities extended to closely-held private companies, particularly where collateral coverage is thin. This is a significant personal risk decision that deserves explicit negotiation — the scope of the guarantee (full amount vs. a capped amount), and whether it can be released upon reaching certain repayment milestones, are all negotiable points, not standard terms to accept without discussion.

Not typically from the same instrument or the same immediate counterparty in the same transaction, but yes at a structural level — venture debt providers, for example, often lend specifically to companies that have recently closed or are closing an equity round, using the equity round as validation and sometimes taking board observer or warrant rights alongside the loan. This blended structure — equity round followed by a venture debt facility sized against the fresh equity cushion — is increasingly common for growth-stage companies wanting to extend runway without further dilution.

A consortium arrangement is when multiple banks jointly fund a large credit facility under a common set of terms, with one bank acting as lead. A multiple banking arrangement is when a company borrows separately from more than one bank without a formal consortium agreement, each bank taking its own security and setting its own terms independently. Larger facilities — beyond what a single bank's exposure limits or risk appetite for one borrower typically allow — often require either structure. Consortium arrangements offer coordinated terms but slower decision-making (all consortium banks must generally agree to changes); multiple banking offers more flexibility but risks inconsistent security and intercreditor complications.

Working capital facilities (cash credit, overdraft, or working capital demand loans) are sized against the operating cycle — receivables, inventory, and payables — typically assessed through the Maximum Permissible Bank Finance (MPBF) methodology or a turnover-based method depending on the lender and facility size. Term loans are sized against specific capex or asset acquisition, with tenor matched to the useful life of the asset being financed and repayment structured against the projected cash flow generation from that asset. We size each component separately rather than requesting a single blended facility, because lenders themselves appraise and price these differently.

The financial model translates the business plan into numbers a lender or investor can stress-test — revenue build-up by driver, cost structure, working capital assumptions, capex schedule, and resulting cash flow, profitability, and balance sheet projections, typically over 3–5 years. It needs to be detailed enough to withstand assumption-by-assumption questioning (why this growth rate, why this margin, why this customer acquisition cost) but not so granular that it becomes fragile to small assumption changes. A credible base case alongside a downside sensitivity case is now close to a baseline expectation from sophisticated lenders and investors alike.

Both. Debt syndication is, if anything, more commonly used by established manufacturing, trading, and services businesses raising working capital or project finance than by early-stage startups. Equity fund raising spans early-stage venture rounds through growth-stage private equity for established, profitable businesses seeking expansion capital without taking on additional leverage. The advisory approach — requirement assessment, instrument selection, materials preparation, negotiation support — applies across both contexts, adapted to the specific lender/investor audience each business type attracts.

Once a facility is disbursed, the borrower typically must submit periodic financial statements and stock/book-debt statements (for working capital facilities) to the lender as per sanction terms, maintain financial covenants (DSCR, current ratio, debt-equity ratio, and others as specified), and obtain lender consent before certain corporate actions (additional borrowing, change in shareholding beyond specified thresholds, dividend payment in some cases) if the sanction letter includes such conditions. Missing periodic reporting or breaching a covenant — even a technical breach with no missed payment — can trigger default clauses and cross-default provisions across other facilities.

Post-closing obligations typically include: board meeting cadence and information delivery to investor board members or observers as per the Shareholders' Agreement, updated statutory registers and cap table reflecting the new allotment, Form PAS-3 filing with MCA within 15 days of allotment, FC-GPR filing within 30 days if any investor is non-resident, and — for any company with foreign shareholding — the Annual Return on Foreign Liabilities and Assets (FLA return) to the RBI by 15 July each year regardless of whether there was any transaction during the year.

Raising fresh debt with an existing default on record is very difficult — credit bureau records and CIBIL defaults are visible to any new lender and are close to disqualifying for a fresh facility until the default is regularised or settled. Raising equity with an existing debt default is possible but requires full disclosure to the investor and typically becomes a condition precedent that the raised equity proceeds be used, at least partly, to resolve the existing default. In either scenario, this shifts from a standard fund-raising mandate into debt restructuring or distressed-situation advisory territory, which PNPC also supports as a separate but related engagement.

Pre-money valuation is the agreed value of the company before the new investment is added; post-money valuation is pre-money plus the amount being raised. The investor's ownership percentage is calculated as the investment amount divided by the post-money valuation. Confusion between the two — common when a valuation figure is quoted without specifying which one it refers to — leads to a mismatch between what the founder believes they are giving up and what the term sheet actually specifies, particularly when an ESOP pool top-up is added into the pre-money calculation (a standard but founder-unfriendly practice that increases effective dilution).

Founders and promoters can absolutely approach lenders and investors directly — many do. What a practising CA firm adds is: a financial case prepared to the standard a credit committee or investment committee actually expects, an independent view on which instrument and structure genuinely fits the business (rather than whichever a broker is incentivised to sell), negotiation support on the terms that matter beyond the headline number, pre-emptive resolution of compliance and documentation gaps before diligence exposes them, and continuity — we remain your CA for the compliance obligations that follow closing, not just for the transaction itself.

PNPC agrees a professional fee in writing before any engagement begins, scoped to the specific mandate — financial model and materials preparation, lender/investor identification and approach, negotiation support, and closing documentation review. The exact structure depends on the size and complexity of the raise and is confirmed in a written scope and fee letter before work starts. We do not publish a standard percentage rate because the appropriate fee structure genuinely differs between a straightforward bank facility renewal and a complex, multi-investor priced equity round with cross-border elements.